Articles tagged "Infection"

2020 American Transplant Congress
Adenovirus Infection in Kidney Transplant Recipients: A Case Series
S. Anjan, Y. Natori, M. Raja, J. Camargo, J. Simkins, M. Morris, A. Fernandez, G. Ciancio, L. Chen, G. Burke, M. Ortigosa-Goggins, J. Pagan, A. Mattiazzi, G. Guerra, L. Abbo
University of Miami/Jackson Memorial Hospital, Miami, FL
*Purpose: Adenovirus (AdV) is associated with poor outcomes in immunosuppressed patients and data on incidence and management in kidney transplant (KT) recipients is limited. *Methods:…
2020 American Transplant Congress
Efficacy and Tolerability of Tedizolid Phosphate in the Treatment of Mycobacterium Abscessus Infection among Pediatric Hematopoietic Stem Cell Transplant Recipients
Y. Kang, V. M. Aquino, A. Y. Koh, D. Wetzel, P. K. Sue
Pediatrics, UT Southwestern Medical Center, Dallas, TX
*Purpose: Mycobacterium abscessus complex infections are associated with high rates of morbidity and mortality in immunocompromised hosts. Treatment can be challenging due to broad spectrum…
2020 American Transplant Congress
Treatment of BK Viremia in Kidney Transplant Recipients: A Single-Center Experience
M. Chaung, E. Hollinger, M. Brokhof, N. Kenyon, L. Lineberger, N. Alvey
Rush University Medical Center, Chicago, IL
*Purpose: Over the past 10 years, our center has utilized various strategies in managing BK viremia in our kidney transplant recipients. Reducing immunosuppression (IMS) in…
2020 American Transplant Congress
Ehrlichiosis Infection Presenting as Thrombotic Microangiopathy Early after Kidney Transplantation
W. Hassan¹, M. Talwar², V. Balaraman², B. Wall¹, M. Molnar¹
¹Medicine-Nephrology, University of Tennessee Health Science Center, Memphis, TN, ²Department of Surgery, Transplant Surgery, Methodist University Hospital, James D Eason Transplant Institute, Memphis, TN
*Purpose: Fever of unknown origin and clinical picture of Thrombotic MicroAngiopathy (TMA) are diagnostic challenges in the early period after kidney transplantation. Here we present…
2020 American Transplant Congress
Peritoneal Dialysis in Delayed Graft Function, a Safe and Effective Option
A. Gardezi, B. Muth, F. Aziz, N. Garg, M. Mohamed, A. Djamali, D. Mandelbrot, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Peritoneal dialysis (PD) has been utilized increasingly in the past decade. Many of these patients undergo transplantation and may require dialysis for delayed graft…
2020 American Transplant Congress
Infectious Complications in Elderly Kidney Transplant Recipients Undergoing Desensitization
S. Sethi, R. Najjar, A. Peng, A. Vo, S. Jordan, E. Huang
Cedars Sinai Medical Center, West Hollywood, CA
*Purpose: Data is limited on the impact of desensitization on infectious complications in elderly kidney transplant (KT) recipients. We examined infectious complications in elderly KT…
2020 American Transplant Congress
Impact of Donor Multidrug-Resistant Organisms on Risk of Recipient Infection
J. A. Anesi¹, E. A. Blumberg¹, J. H. Han², D. H. Lee³, H. Clauss⁴, R. Hasz⁵, E. Molnar⁴, D. Alimenti¹, A. R. Motzer⁴, S. West⁵, W. B. Bilker¹, P. Tolomeo¹, E. Lautenbach¹, T. Prevention Epicenters Program⁶
¹University of Pennsylvania, Philadelphia, PA, ²GlaxoSmithKline, Rockville, MD, ³Drexel University, Philadelphia, PA, ⁴Temple University, Philadelphia, PA, ⁵Gift of Life Donor Program, Philadelphia, PA, ⁶Centers for Disease Control and Prevention, Atlanta, GA
*Purpose: Although there is concern about the use of donor organs that are infected or colonized with multidrug-resistant organisms (MDROs), their impact on solid organ…
2020 American Transplant Congress
Letermovir Treatment for Established Cytomegalovirus Infection in Transplant Recipients
K. Linder¹, C. Kovacs², K. Mullane³, C. Wolfe⁴, N. Clark⁵, C. Butkus Small⁶, R. La Hoz⁷, J. Smith⁸, C. Kotton⁹, A. Limaye¹⁰, M. Malinis¹¹, M. Hakki¹², A. Mishkin¹³, A. Gonzalez¹⁴, D. Kaul¹
¹U Michigan, Ann Arbor, MI, ²Cleveland Clinic, Cleveland, OH, ³U Chicago, Chicago, IL, ⁴Duke, Durham, NC, ⁵Loyola, Chicago, IL, ⁶Cornell, NYC, NY, ⁷UTSW, Dallas, TX, ⁸U Wisconsin, Madison, WI, ⁹Mass General, Boston, MA, ¹⁰U Washington, Seattle, WA, ¹¹Yale, New Haven, CT, ¹²OHSU, Portland, OR, ¹³Temple, Philadelphia, PA, ¹⁴West Coast ID, Safety Harbor, FL
*Purpose: The purpose of the study was to describe the patterns of use and clinical/virologic outcomes of letermovir treatment for established CMV infection in transplant…
2020 American Transplant Congress
Utilization of Hepatitis C Viremic Donors in Liver Transplantation. A Single Center Experience
R. Cohen, N. Chandolias*, K. Khanmoradi, S. Campos, H. Kaul, J. Walter, S. Rossi, V. Navarro, R. Zaki
Department of Digestive Disease and Transplantation, Albert Einstein Medical Center, Philadelphia, PA
*Purpose: The evolution of effective direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV), in the setting of the well recognized organ shortage and the…
2020 American Transplant Congress
Hyperammonemia Syndrome in a Kidney Transplant Recipient Caused by Quinolone-Resistant Ureaplasma Infection
A. B. Higgins¹, R. Rogers², A. J. Osband³, R. Gohh⁴, P. Morrissey³, A. Seo¹, B. Chen¹, D. Crabb⁵, S. Leal⁵, K. Waites⁵, D. Farmakiotis², G. J. Nau²
¹Department of Medicine, Alpert Medical School of Brown University, Providence, RI, ²Division of Infectious Diseases, Alpert Medical School of Brown University, Providence, RI, ³Department of Surgery, Alpert Medical School of Brown University, Providence, RI, ⁴Division of Nephrology, Alpert Medical School of Brown University, Providence, RI, ⁵Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Urease-producing bacteria release significant amounts of ammonia. Donor-derived Ureaplasma infections in lung transplant recipients have been implicated in the pathogenesis of hyperammonemia syndrome (HS).…